Equities

Beijing Luzhu Biotechnology Co Ltd

Beijing Luzhu Biotechnology Co Ltd

Actions
  • Price (HKD)21.60
  • Today's Change0.65 / 3.10%
  • Shares traded3.20k
  • 1 Year change-34.64%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 05:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments608582564
Total Receivables, Net------
Total Inventory3.482.545.32
Prepaid expenses9.17174.58
Other current assets, total------
Total current assets621601574
Property, plant & equipment, net488292142
Goodwill, net------
Intangibles, net4.133.440
Long term investments--00
Note receivable - long term------
Other long term assets------
Total assets1,1671,070726
LIABILITIES
Accounts payable------
Accrued expenses4.29154.26
Notes payable/short-term debt7.0000
Current portion long-term debt/capital leases0.13----
Other current liabilities, total857919
Total current liabilities969423
Total long term debt12111,248
Total debt19111,248
Deferred income tax------
Minority interest------
Other liabilities, total382739
Total liabilities1461331,310
SHAREHOLDERS EQUITY
Common stock20219291
Additional paid-in capital2,4482,20074
Retained earnings (accumulated deficit)(1630)(1454)(750)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,021937(585)
Total liabilities & shareholders' equity1,1671,070726
Total common shares outstanding202202202
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.